Cargando…

Nonpharmacological Interventions for the Treatment of Cardiometabolic Risk Factors in People With Schizophrenia—A Systematic Review

Background: People suffering from schizophrenia are notably vulnerable to cardiometabolic risk factors (CMRF), such as obesity, high blood pressure, hyperglycemia and insulin resistance, high serum triglycerides, and low serum high-density lipoprotein (HDL), which are related to increased mortality...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tumiel, Ewa, Wichniak, Adam, Jarema, Marek, Lew-Starowicz, Michał
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709656/ https://www.ncbi.nlm.nih.gov/pubmed/31481903 http://dx.doi.org/10.3389/fpsyt.2019.00566

Ejemplares similares

Exploring Factors Associated With Successful Nonpharmacological Interventions for People With Dementia
por: Park, HyounKyoung Grace, et al.
Publicado: (2022)

Nonpharmacological interventions in COPD
por: Janssens, Wim, et al.
Publicado: (2023)

When practice does not make a perfect - paradoxical learning curve in schizophrenia and bipolar disorder revealed by different serial reaction time task variants
por: Chrobak, Adrian Andrzej, et al.
Publicado: (2023)

Integrated Analysis of Summary Statistics to Identify Pleiotropic Genes and Pathways for the Comorbidity of Schizophrenia and Cardiometabolic Disease
por: Liu, Hao, et al.
Publicado: (2020)

Rehabilitation Interventions to Promote Recovery from Schizophrenia: A Systematic Review
por: Morin, Laurent, et al.
Publicado: (2017)

A Systematic Review of Psychosocial Barriers and Facilitators to Smoking Cessation in People Living With Schizophrenia
por: Lum, Alistair, et al.
Publicado: (2018)

Worth the Weight? Olanzapine Prescribing in Schizophrenia. A Review of Weight Gain and Other Cardiometabolic Side Effects of Olanzapine
por: Fitzgerald, Ita, et al.
Publicado: (2021)

COVID-19 in People With Schizophrenia: Potential Mechanisms Linking Schizophrenia to Poor Prognosis
por: Mohan, Mohapradeep, et al.
Publicado: (2021)

Investigating the Agreement Between Cardiovascular Disease Risk Calculators Among People Diagnosed With Schizophrenia
por: Berry, Alexandra, et al.
Publicado: (2018)

Nonpharmacological treatment of dyscognition in schizophrenia: effects  of aerobic exercise 
por: Maurus, Isabel, et al.
Publicado: (2019)

Neuromodulation to Treat Substance Use Disorders in People With Schizophrenia and Other Psychoses: A Systematic Review
por: Johnstone, Samantha, et al.
Publicado: (2022)

Dog-assisted interventions for adults diagnosed with schizophrenia and related disorders: a systematic review
por: Tyssedal, Malene Kalsnes, et al.
Publicado: (2023)

Development of the Positive Emotions Program for Schizophrenia: An Intervention to Improve Pleasure and Motivation in Schizophrenia
por: Nguyen, Alexandra, et al.
Publicado: (2016)

Nonpharmacologic Interventions in Prevention and Treatment of Hypertension
por: Erejuwa, Omotayo O., et al.
Publicado: (2019)

BUDGET IMPACT ANALYSIS OF NONPHARMACOLOGICAL INTERVENTIONS FOR COMMUNITY-DWELLING PEOPLE LIVING WITH DEMENTIA
por: Jutkowitz, Eric, et al.
Publicado: (2022)

Clubhouse Model of Psychiatric Rehabilitation in China to Promote Recovery of People With Schizophrenia: A Systematic Review and Meta-Analysis
por: Yan, Haohao, et al.
Publicado: (2021)

Nonpharmacological management of psychological distress in people with COPD
por: Volpato, Eleonora, et al.
Publicado: (2023)

Vocational Profile and Correlates of Employment in People With Schizophrenia: The Role of Avolition
por: Ang, Mei San, et al.
Publicado: (2020)

Referential communication in people with recent-onset schizophrenia-spectrum disorders
por: Achim, Amélie M., et al.
Publicado: (2022)

Psychological Interventions for Young People With Psychotic Disorders: A Systematic Review
por: Gergov, Vera, et al.
Publicado: (2022)

Pharmacological Interventions to Treat Antipsychotic-Induced Dyslipidemia in Schizophrenia Patients: A Systematic Review and Meta Analysis
por: Kanagasundaram, Pruntha, et al.
Publicado: (2021)

Brain-Specific Oxysterols and Risk of Schizophrenia in Clinical High-Risk Subjects and Patients With Schizophrenia
por: Sun, Zuoli, et al.
Publicado: (2021)

Economic evidence for nonpharmacological asthma management interventions: A systematic review
por: Crossman‐Barnes, C‐J., et al.
Publicado: (2017)

Nonpharmacological Interventions for Anxiety and Dementia in Nursing Homes: A Systematic Review
por: Brown Wilson, Christine, et al.
Publicado: (2019)

Nonpharmacological interventions for osteoporosis treatment: Systematic review of clinical practice guidelines
por: Coronado-Zarco, Roberto, et al.
Publicado: (2019)

Increased Mortality in Schizophrenia Due to Cardiovascular Disease – A Non-Systematic Review of Epidemiology, Possible Causes, and Interventions
por: Ringen, Petter Andreas, et al.
Publicado: (2014)

A Systematic Review of Exercise Intervention Program for People With Substance Use Disorder
por: Zhang, Zhilei, et al.
Publicado: (2022)

Reducing Smoking Among People With Schizophrenia: Perspectives on Priorities for Advancing Research
por: Baker, Amanda L., et al.
Publicado: (2018)

Absence of Excess Intra-Individual Variability in Retinal Function in People With Schizophrenia
por: Fradkin, Samantha I., et al.
Publicado: (2020)

An Evaluation of an Online Training Platform for Teaching Positive Emotions for People With Schizophrenia
por: Nguyen, Alexandra, et al.
Publicado: (2022)

Personal Recovery and Its Determinants Among People Living With Schizophrenia in China
por: Yu, Yu, et al.
Publicado: (2020)

Editorial: Cardiometabolic disease and psychiatric disorders
por: Deste, Giacomo, et al.
Publicado: (2023)

Differentiation of the retinal morphology aging trajectories in schizophrenia and their associations with cognitive dysfunctions
por: Domagała, Adam, et al.
Publicado: (2023)

Erratum to “Nonpharmacologic Interventions in Prevention and Treatment of Hypertension”
por: Erejuwa, Omotayo O., et al.
Publicado: (2019)

Hypoxic exercise as an effective nonpharmacological therapeutic intervention
por: Brocherie, Franck, et al.
Publicado: (2020)

Identifying Modifiable Risk Factors for Relapse in Patients With Schizophrenia in China
por: Mi, Wei-Feng, et al.
Publicado: (2020)

Risk factors for violence among female forensic inpatients with schizophrenia
por: Wolf, Viviane, et al.
Publicado: (2023)

Psychosocial Factors Affecting Smoking Cessation Among People Living With Schizophrenia: A Lived Experience Lens
por: Cocks, Nadine, et al.
Publicado: (2019)

What factors should we modify to promote high functioning and prevent functional decline in people with schizophrenia?
por: Martínez-Cao, Clara, et al.
Publicado: (2023)

Efficacy of immersive extended reality (XR) interventions on different symptom domains of schizophrenia spectrum disorders. A systematic review
por: Holopainen, Roope, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4jk6c2a8o0d8c8oiafntcl8avf